1H and 13C spectral assignment of o‐chloroformyl substituted 1,4‐dihydropyridine derivatives

The 1H and 13C NMR spectroscopic data for alkyl 4‐aryl‐6‐chloro‐5‐formyl‐2‐methyl‐1,4‐dihydopyridine‐3‐carboxylates were fully assigned by combination of one‐ and two‐dimensional experiments (DEPT, HMBC, HMQC, COSY, NOE). Copyright © 2002 John Wiley & Sons, Ltd.

[1]  H. D. Armas.  Experimental and Theoretical Structural Study of 2-Pyridyl- and 4-Hydroxyphenyl-1,4-dihydropyridine Derivatives. , 2001 .

[2]  N. Martín,et al.  1H and 13C spectral assignment of 1,4,5,6,7,8‐hexahydroquinolines and their oxa‐analogues 5,6,7,8‐tetrahydro‐4H‐chromenes , 2001 .

[3]  N. Martín,et al.  Synthesis and structural study of novel 1,4,5,6,7,8-hexahydroquinolines† , 2000 .

[4]  N. Martín,et al.  Synthesis and Structural Study of 3,4‐Dihydro‐2(1H)‐pyridones and Isoxazolo[5,4‐b]pyridin‐6(7H)‐ones , 2000 .

[5]  M. Suárez,et al.  Synthesis, crystal structure, and molecular modeling (AM1) of Methyl 6-chloro-4-(2-chlorophenyl)-5-formyl-2-methyl-1, 4-dihydropyridine-3-carboxylate , 2000 .

[6]  N. Martín,et al.  A joint experimental and theoretical structural study of novel substituted 2,5-dioxo-1,2,3,4,5,6,7,8-octahydroquinolines , 1999 .

[7]  J. Duque,et al.  Structural study of 3,4-dihydropyridones and furo[3,4-b]-2(1H)-pyridones as potential calcium channel modulators , 1998 .

[8]  N. Martín,et al.  Synthesis and structural characterization of substituted thieno[2,3-b]pyridines from o-chloroformyl-1,4-dihydropyridines , 1997 .

[9]  S. Goldmann,et al.  1,4‐Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities , 1991 .

[10]  Á. Guzmán,et al.  Vilsmeier-Haack reaction with glutarimides. Synthesis of 2,6-dichloro-1,4-dihydropyridine-3,5-dicarboxaldehydes , 1990 .

[11]  F. Bossert,et al.  1,4‐Dihydropyridines—a basis for developing new drugs , 1989, Medicinal research reviews.

[12]  C. Romming,et al.  Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine. , 1982, Journal of medicinal chemistry.

[13]  A M Triggle,et al.  Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine. , 1980, Journal of medicinal chemistry.

[14]  N. Martín,et al.  Synthesis of methyl 4-aryl-6-methyl-4,7-dihydro-1H-pyrazolo-[3,4-b]pyridine-5-carboxylates from methyl 4-aryl-6-methyl-2-oxo-1,2,3,4-tetrahydropyridine-5-carboxylates , 1996 .